cropped-gtc_logo_grey_circle_2022

Utilize the first AI software for diagnosing DLBCL

Utilize the first AI software for diagnosing DLBCL

GTC is the first and only diagnostic lab to deploy true artificial intelligence (AI) software for classifications of lymphoma.

Do not accept partial results, send your lymphoma to GTC for comprehensive classification using RNA/DNA and artificial intelligence. Get results in 7 days for DNA and 10 days for RNA

A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

GTC was recently published in Blood Advances with an article titled (click URL below to read it):
A refined cell-of-origin classifier with targeted NGS and artificial intelligence shows robust predictive value in DLBCL

Key points:
– A DLBCL cell-of-origin classifier integrating both genetic and gene expression signatures show robust predictive values in DLBCL cohorts.
– Targeted NGS and AI enable potential applications of fast and reliable DLBCL classification assays in clinical practice.

GTC’s hematology profiles are covered by Medicare. To learn more contact us info@Genomictestingcooperative.com

YOU MAY ALSO ENJOY THESE ARTICLES:

Τumor-informed vs Tumor-naïve

Liquid biopsies are a rapidly evolving diagnostic technology with numerous labs offering commercially available tests today. Most labs have taken an approach of cell-free (cfDNA) (also called circulating tumor DNA,

Read More »

Subscribe to our Newsletter

Get all the critical news and events sent straight to your inbox

Share this post with your friends

Leave a Reply